tirzepatide retatrutide vs. GLP- Tirz + Reta –

Uncover the secrets to navigating stalls, fluctuations, and success on GLP-1 medications

Enhanced GLP-1 targets your bodys natural appetite pathway the same GLP-1 system that prescription drugs manipulate using eight plant-based, clinically studied ingredients

Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials

Discover how semaglutide and other GLP-1 medications affect digestion, when stool colour changes need medical attention, and practical management strategies for gastrointestinal side effects.

Discover how Thrive and InBody protect lean mass to ensure lasting, healthy results.

By payor, prescriptions per enrollee-member increased fastest for Medicare, as volume grew three times faster than enrollment as members were using more prescriptions about 35 per enrollee in 2023